Investor Relations

Press Releases

Date Title and Summary View
Toggle Summary NanoString Technologies Announces Pricing of Offering of 3,000,000 Shares of Common Stock
SEATTLE , June 01, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of an underwritten public offering of 3,000,000 shares of its common stock at a price
View HTML
Toggle Summary NanoString Technologies Announces Offering of Common Stock
SEATTLE , May 31, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an agreement to sell 2,750,000 shares of its common stock to Robert W. Baird & Co.
View HTML
Toggle Summary NanoString to Webcast Presentation at the 2017 Jefferies Healthcare Conference
SEATTLE , May 30, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies , Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it will webcast the company's presentation at the 2017 Jefferies Healthcare Conference in New
View HTML
Toggle Summary NanoString Highlights Record Number of nCounter-Related Research Abstracts Showcasing Advances in Precision Oncology at the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
More than 35 Abstracts Demonstrate the Value of the nCounter Platform for Targeted Discovery, Biomarker Development and Diagnostic Applications in Cancer Research and Immuno-Oncology NanoString's New Digital Spatial Profiling Technology Featured in Two Abstracts SEATTLE , May 25, 2017 (GLOBE
View HTML
Toggle Summary NanoString Appoints Elisha W. Finney to Board of Directors
SEATTLE , May 10, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Elisha W. Finney , former executive vice president and chief financial officer at
View HTML
Toggle Summary NanoString Technologies Releases Operating Results for First Quarter of 2017
SEATTLE , May 04, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the first quarter of 2017. First Quarter Financial Highlights Total revenue of
View HTML
Toggle Summary NanoString Technologies to Release First Quarter 2017 Financial Results and Host Conference Call on Thursday, May 4, 2017
SEATTLE , April 05, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release first quarter 2017 financial results after the close of trading on
View HTML
Toggle Summary Digital Spatial Profiling Technology Enables Quantitative Protein Profiling in FFPE Tissue Providing Detailed Molecular Characterization of Immune Response to Tumors
The Yale School of Medicine Presents Validation of NanoString's Novel Digital Spatial Profiling Technology by Quantitative Immunofluorescence Technology at 2017 American Association for Cancer Research
View HTML
Toggle Summary NanoString Launches Multiple New Products at AACR 2017 to Advance Precision Oncology Research
New Offerings Include nCounter Platform Enhancements as Well as New Panels That Expand NanoString's Footprint in Immuno-oncology and 3D Biology Research
View HTML
Toggle Summary NanoString Highlights a Record Number of nCounter-Based Research Abstracts in Precision Oncology and Predictive Biomarkers at the 2017 American Association of Cancer Research (AACR) Annual Meeting
More than 45 Abstracts Demonstrate the Unique Capabilities of the nCounter Analysis System for Disease Characterization in Cancer Research and Immuno-Oncology
View HTML